WARD-COPD: Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease
Study design
Prospective observational study
Sample size
200 participants
Study sites
Bispebjerg Hospital
Inclusion criteria
Adult (>18 years) patients admitted with acute exacerbation of COPD (admission diagnosis)
Study procedures
Included patients are monitored with WARD equipment from admission and up to 4 days forward during hospitalization.
Primary outome
Severe adverse events (SAE’s) at 30 days and 6 months after study inclusion.
Primary Investigator
Mikkel Elvekjær, MD, PhD student
NCT
NCT03660501